Craig Hopkinson, M.D., is responsible for evolving and executing the clinical development programs for the company’s pipeline of drug candidates. Dr. Hopkinson has more than 20 years of experience building and leading clinical development organizations and medical affairs groups in the biopharmaceutical industry. He has led multidisciplinary development teams in multiple therapeutic areas, including neuroscience, oncology, gastroenterology, infectious diseases, cardiovascular conditions, inflammation, genetic diseases, hematology and neurodegenerative diseases, and has extensive knowledge of clinical study design and the regulatory landscape. Most recently, Dr. Hopkinson held the position of Senior Vice President and Head of Global Medical Affairs for Vertex Pharmaceuticals. Prior to this role, Dr. Hopkinson held various executive management positions at Eisai Pharmaceuticals, including President of Eisai Value Maximization Systems, President and Chief Medical Officer of the Frontier Product Creation Unit, and Vice President of Medical Affairs, Oncology. In addition, Dr. Hopkinson served in leadership positions at Elan Pharmaceuticals, Actelion Pharmaceuticals and Pfizer. Dr. Hopkinson completed his Bachelor of Medicine and Bachelor of Surgery at the University of the Orange Free State in South Africa.